| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 94,4 k € | -1.4% | 95,7 k € | -0.4% | 96,1 k € | +5.3% | 91,2 k € | -14.4% | 106,5 k € | -3.1% | 109,9 k € | +100.5% | 54,8 k € | -30.3% | 78,6 k € | -4.8% | 82,5 k € | -11.8% | 93,6 k € | +17.3% | 79,7 k € | -18.2% | 97,5 k € | +192.6% | 33,3 k € | -13.5% | 38,5 k € | -5.1% | 40,6 k € | |
| EBITDA | 94,4 k € | -1.2% | 95,6 k € | -0.1% | 95,7 k € | +5.0% | 91,1 k € | -14.4% | 106,4 k € | -2.8% | 109,5 k € | +101.2% | 54,4 k € | -30.4% | 78,2 k € | -4.7% | 82,0 k € | -11.9% | 93,1 k € | +17.4% | 79,3 k € | -17.8% | 96,5 k € | +196.0% | 32,6 k € | -14.4% | 38,1 k € | +0.1% | 38,0 k € | |
| Operating profit | 88,8 k € | +1.8% | 87,2 k € | -0.2% | 87,3 k € | +5.5% | 82,8 k € | -15.6% | 98,1 k € | -8.0% | 106,6 k € | +96.9% | 54,1 k € | -30.5% | 77,9 k € | -4.4% | 81,5 k € | -11.8% | 92,4 k € | +28.6% | 71,9 k € | -17.4% | 87,0 k € | +274.0% | 23,3 k € | -20.8% | 29,4 k € | +7.4% | 27,4 k € | |
| Profit/loss | 270,0 k € | +125.5% | 119,7 k € | +31.1% | 91,4 k € | -8.4% | 99,8 k € | +95.6% | 51,0 k € | -13.4% | 58,9 k € | -76.6% | 252,2 k € | +709.1% | 31,2 k € | -7.3% | 33,6 k € | -29.6% | 47,7 k € | +49.7% | 31,9 k € | -21.8% | 40,8 k € | +199.7% | 13,6 k € | -33.1% | 20,3 k € | +11.3% | 18,3 k € | |
| Equity | 962,6 k € | +13.2% | 850,6 k € | +11.6% | 762,0 k € | +8.2% | 704,3 k € | +16.5% | 604,5 k € | +9.2% | 553,5 k € | +11.9% | 494,6 k € | +104.1% | 242,4 k € | +14.8% | 211,2 k € | +18.9% | 177,6 k € | +36.7% | 129,9 k € | +32.5% | 98,0 k € | +71.2% | 57,2 k € | +31.2% | 43,6 k € | +87.4% | 23,3 k € | |
| Total assets | 1,1 M € | -0.9% | 1,2 M € | -0.1% | 1,2 M € | -1.1% | 1,2 M € | -1.0% | 1,2 M € | -0.6% | 1,2 M € | +2.8% | 1,2 M € | -0.5% | 1,2 M € | -0.3% | 1,2 M € | -0.0% | 1,2 M € | -0.0% | 1,2 M € | +6.8% | 1,1 M € | -2.6% | 1,1 M € | +1178.1% | 87,5 k € | +36.2% | 64,3 k € | |
| Cash | 8,2 k € | -37.8% | 13,1 k € | +104.2% | 6,4 k € | -27.9% | 8,9 k € | -29.2% | 12,6 k € | -4.9% | 13,2 k € | +104.2% | 6,5 k € | +5.1% | 6,2 k € | -15.5% | 7,3 k € | +61.6% | 4,5 k € | -55.8% | 10,2 k € | -61.5% | 26,6 k € | -83.1% | 157,5 k € | +204.8% | 51,7 k € | +109.8% | 24,6 k € | |
| Debts | 180,4 k € | -40.4% | 302,6 k € | -23.0% | 392,9 k € | -15.1% | 462,9 k € | -19.5% | 574,9 k € | -9.2% | 633,0 k € | -4.0% | 659,6 k € | -28.1% | 917,9 k € | -3.6% | 952,5 k € | -3.4% | 986,2 k € | -4.7% | 1,0 M € | +4.3% | 992,0 k € | -6.6% | 1,1 M € | +2317.9% | 43,9 k € | +7.1% | 41,0 k € | |
Private limited company · Ternat · incorporated on 16/11/2010
Private limited company profitable and well capitalised. Cash position declining (-37.8%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
POP Pharma is a Private limited company incorporated in 2010. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Ternat.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette